Vimarsana
Biggest News Aggregation in the World

William Brinkerhoff News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from William Brinkerhoff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In William Brinkerhoff Today - Breaking & Trending Today

Chicago looks to end ebola virus monitoring | Crain's Chicago Business - Vimarsana News

Chicago looks to end ebola virus monitoring | Crain's Chicago Business

Crain's Health Pulse is your source for actionable, exclusive and inside news on the health care industry.

EVOQ Therapeutics Expands Leadership Team with David Giljohann, Ph.D., as Chief Executive Officer and Greg Barrett as Chief Operating Officer - Vimarsana News

EVOQ Therapeutics Expands Leadership Team with David Giljohann, Ph.D., as Chief Executive Officer and Greg Barrett as Chief Operating Officer

/PRNewswire/ -- EVOQ Therapeutics, Inc. (EVOQ), a biopharmaceutical company focused on the discovery and development of drugs to treat patients afflicted with...

Ann Arbor-based Evoq replaces CEO | Crain's Detroit Business - Vimarsana News

Ann Arbor-based Evoq replaces CEO | Crain's Detroit Business

A week after signing a lucrative licensing agreement, the top management at Ann Arbor-based pharmaceutical startup Evoq Therapeutics Inc. gets replaced. The company announced last week that public biopharmaceutical conglomerate Gilead Sciences Inc. would license its rheumatoid arthritis and lupus…

David Giljohann named CEO of Evoq | Crain's Chicago Business - Vimarsana News

David Giljohann named CEO of Evoq | Crain's Chicago Business

Giljohann departed the CEO role at Exicure with other top executives amid sustained money loss in 2021 but remained with the company as a board member until February 2022.

Gilead and EVOQ Therapeutics Announce Collaboration to Advance Immunotherapies - Vimarsana News

Gilead and EVOQ Therapeutics Announce Collaboration to Advance Immunotherapies

Gilead Sciences, Inc. (Nasdaq: GILD) and EVOQ Therapeutics, Inc. (EVOQ) today announced a collaboration and licensing agreement to advance EVOQ’s proprietary technology for the treatment of rheumatoid arthritis (RA) and lupus. EVOQ’s NanoDisc technology is designed to enable lymph-targeted delivery of ...